Asterion

Asterion is a Belgian biotechnology company specializing in dermatology and aesthetic medicine through the application of genetic engineering and protein design. The company's core technology, the Phagendo platform, utilizes bacteriophage-derived endolysins to create highly specific antimicrobial agents that target resistant bacteria in inflammatory skin conditions. Beyond antimicrobials, Asterion is developing a portfolio of dermo-cosmetic and pharmaceutical candidates, including Aster-1206X19 for diabetic foot ulcers and various treatments for UV-induced skin damage and premature aging. The company employs a sustainable plant-based production system, using plants as "mini bio-factories" to manufacture its complex therapeutic proteins. Asterion has established strategic partnerships, notably with Kalbe Farma, to commercialize its aesthetic and dermatological products in international markets.